(Q37589672)

21 August 2017

1 reference

title

Exenatide efficacy and safety: a systematic review (English)

1 reference

21 August 2017

1 reference

S L Norris

1

1 reference

21 August 2017

N Lee

series ordinal

2

1 reference

21 August 2017

S Thakurta

series ordinal

3

1 reference

21 August 2017

B K S Chan

series ordinal

4

1 reference

21 August 2017

publication date

1 September 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

26

1 reference

21 August 2017

issue

9

1 reference

21 August 2017

page(s)

837-846

1 reference

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02790.X

Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02790.X

Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02790.X

The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2009.02790.X

10.1111/J.1464-5491.2009.02790.X

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference